Clinically, the expression ratio of MITF and c-Jun could reflect the recruitment and infiltration of myeloid cells in tumor microenvironment, thus dictating the sensitivity to myeloid cells-directed immunotherapy.346 Some recent studies have also emphasized the role of TNFα in anti-tumor immunity and immunotherapy. The gene discussed is MITF; the disease is neoplasm.